Search

everythinglearnresearchcommunity

for

Search:↓

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Some breast cancer chemotherapy can cause permanent hair loss.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Researchers created hair-inducing human cell clusters using a 3D culture method.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Fat cells are important for tissue repair and stem cell support in various body parts.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Extramammary Paget disease can spread deeply into tissues, reaching up to 3.6 mm.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.